20170406 Telix Logo.png
Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited
September 17, 2017 18:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been...
20170406 Telix Logo.png
Cyclotek and Telix Pharmaceuticals Conclude Radiopharmaceutical Manufacturing Agreement for Australia and New Zealand
July 31, 2017 00:59 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, July 31, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”) is pleased to announce the completion of a Master Services Agreement (“MSA”) with Cyclotek (Aust) Pty...
20170406 Telix Logo.png
Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia
January 18, 2017 23:55 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and DRESDEN, Germany, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”) is pleased to announce a product development partnership with Therapeia GmbH...
20170406 Telix Logo.png
Telix Pharmaceuticals and Atlab Pharma Conclude Therapeutic Product Development Agreement for Prostate Cancer
January 18, 2017 17:42 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and NANTES, France, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”) is pleased to announce the completion of a product collaboration and purchase...